FORLEO, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 3.818
EU - Europa 1.117
AS - Asia 549
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.489
Nazione #
US - Stati Uniti d'America 3.803
CN - Cina 348
SE - Svezia 277
IT - Italia 269
SG - Singapore 175
DE - Germania 126
FI - Finlandia 98
RU - Federazione Russa 93
UA - Ucraina 80
GB - Regno Unito 56
FR - Francia 39
BE - Belgio 21
CA - Canada 15
CZ - Repubblica Ceca 12
IE - Irlanda 11
LT - Lituania 11
IN - India 9
NL - Olanda 8
CH - Svizzera 7
VN - Vietnam 6
HK - Hong Kong 5
BR - Brasile 3
IR - Iran 3
ES - Italia 2
SI - Slovenia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
KR - Corea 1
LV - Lettonia 1
PT - Portogallo 1
RO - Romania 1
Totale 5.489
Città #
Fairfield 502
Chandler 398
Woodbridge 392
Houston 324
Ashburn 288
Nyköping 227
Ann Arbor 191
Cambridge 189
Jacksonville 185
Wilmington 164
Seattle 162
Singapore 155
Bari 110
Roxbury 80
Lawrence 78
Nanjing 76
Beijing 68
New York 63
Munich 55
Des Moines 47
Boardman 43
Inglewood 39
Helsinki 37
San Diego 31
Princeton 25
Brussels 21
Hebei 20
Shenyang 19
Brooklyn 16
Dearborn 15
London 15
Nanchang 14
Jinan 12
Paris 12
San Mateo 12
Brno 11
Dublin 11
Marseille 11
Milan 11
Tianjin 11
Guangzhou 10
Shanghai 10
Jiaxing 9
Leawood 9
Santa Clara 9
Toronto 9
Falls Church 8
Naples 8
Changsha 7
Augusta 6
Dong Ket 6
Espoo 6
Foggia 6
Frankfurt am Main 6
Ravenna 6
Redwood City 6
Grottaglie 5
Los Angeles 5
Monmouth Junction 5
Stimigliano 5
Wuhan 5
Hong Kong 4
Norwalk 4
Valenzano 4
Zhengzhou 4
Amsterdam 3
Ardabil 3
Auburn Hills 3
Fuzhou 3
Hefei 3
Kunming 3
Molfetta 3
Pune 3
Romanel-sur-Lausanne 3
San Francisco 3
Triggiano 3
Washington 3
Wuxi 3
Yiwu 3
A Coruña 2
Angeren 2
Atrani 2
Bengaluru 2
Bitonto 2
Chiswick 2
Falkenstein 2
Florence 2
Forlimpopoli 2
Greater Sudbury 2
Grumo Appula 2
Hangzhou 2
Ljubljana 2
Miami 2
New Bedfont 2
Nürnberg 2
Osio Sotto 2
Ottawa 2
Padova 2
Pavia 2
Pescara 2
Totale 4.386
Nome #
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 141
Targeted next-generation sequencing detects novel gene- phenotype associations and expands the mutational spectrum in cardiomyopathies 129
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 128
Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome 127
Independent Role of Left Ventricular Global Longitudinal Strain in Predicting Prognosis of Chronic Heart Failure Patients. 119
Clinical and functional characterization of a novel mutation in lamin a/C gene in a multigenerational family with arrhythmogenic cardiac laminopathy 112
Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis 110
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 105
Beta1-Adrenergic Receptor Polymorphisms Predict Heart Failure Progression in Idiopathic Dilated Cardiomyopathy 103
Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype 94
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 91
Left ventricular ejection fraction and b2-adrenergic receptor polymorphism in dilated cardiomyopathy 89
null 88
Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy 87
Clinical predictors of head-up tilt test outcome during the nitroglycerin phase 85
The 212A Variant of the APJ Receptor Gene for the Endogenous Inotrope Apelin is Associated With Slower Heart Failure Progression in Idiopathic Dilated Cardiomyopathy 84
Alpha- and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring 84
SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene 82
Ventricular Asynchrony Predicts a Better Outcome in Patients With Chronic Heart Failure Receiving Cardiac Resynchronization Therapy 81
Endothelin system polymorphisms in tilt test-induced vasovagal syncope 81
Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy 80
Independent role of high central venous pressure in predicting worsening of renal function in chronic heart failure outpatients 78
Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy 77
null 77
Role of nuclear Lamin A/C in cardiomyocyte functions 77
Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. 74
Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study). 74
Prognostic significance of bioelectrical evaluation of body composition in chronic heart failure 74
Role of septal to posterior wall motion delay in cardiac resynchronization therapy 73
Head-up tilt testing for diagnosing vasovagal syncope: A meta-analysis 71
Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients 71
Alpha1a-Adrenergic Receptor Polymorphisms Influences Baroreflex Sensitivity and Nonsustained Ventricular Tachycardia in Idiopathic Dilated Cardiomyopathy 70
null 70
Altered two-dimensional strain measures of the right ventricle in patients with Brugada syndrome and arrhythmogenic right ventricular dysplasia/cardiomyopathy 70
Nitrate-Potentiated Head-Up Tilt Testing in Older Patients: Outcomes, Hemodynamic Responses and Prodrome Recognition 69
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 69
Functional characterization of a newly identified LMNA mutant in HL-1 cardiomyocytes 67
Arg16Arg genotype of the beta2-adrenergic receptor predicts lower risk for major arrhythmic events in patients with idiopathic dilated cardiomyopathy 67
Echocardiographic characteristics of unaffected relatives of patients with familial and non-familial idiopathic dilated cardiomyopathy 65
Prevalence, timing, and haemodynamic correlates of prodromes in patients with vasovagal syncope induced by head-up tilt test 65
Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian Cancers 63
Independent role of reduced arterial baroreflex sensitivity during head-up tilt testing in predicting vasovagal syncope recurrence 61
Cardiogenic Shock following Acute Myocardial Infarction: What's New? 61
Methodical approach to collecting and preserving plasma samples containing B-type natriuretic peptide 59
Left ventricular hypertrophy and ventricular pre-excitation: let’s not forget Danon disease 59
Lack of association between genetic polymorphisms affecting sympathetic activity and tilt-induced vasovagal syncope 59
Shortened head-up tilting test guided by systolic pressure reductions in neurocardiogenic syncope 58
Association of β-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy 54
Impaired arterial baroreflex function before nitrate-induced vasovagal syncope during head-up tilt test 53
High circulating levels of endogenous ouabain in the offspring of hypertensive and normotensive individuals 52
I livelli plasmatici dell’angiotensina II predicono la risposta alla terapia nei pazienti con scompenso cardiaco 51
Screening For Sarcomere Protein Gene Mutations and Genotype-Phenotype Correlations in Patients with Hypertrophic Cardiomyopathy: experience of a Single Centre 51
VINYL: Variant prIoritizatioN by survivaL analysis 51
Sarcomere gene mutations and clinical correlates in patients with hypertrophic cardiomyopathy 48
Left ventricular hypertrophy: when to suspect Anderson-Fabry disease? 48
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies 47
Beta1- and Beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy 46
null 46
Independent prognostic role of arterial baroreflex control of heart rate in predicting heart failure progression in idiopathic dilated cardiomyopathy 45
Genetic and phenotypic heterogeneity in hypertrophic cardiomyopathy: our experience by using targeted next-generation sequencing 45
Independent prognostic value of baroreflex sensitivity in idiopathic dilated cardiomyopathy 45
Left ventricular systolic dysfunction and conduction system disorders: when do you think about cardiolaminopathy? 44
Role of Beta1-Adrenergic receptor polymorphysms in predicting heart failure progression in idiopathic dilated cardiomyopathy 44
Importance of clinical suspicion and multidisciplinary management for early diagnosis of a cardiac laminopathy patient: A case report 44
Role of polymorphysms in the Beta1-Adrenergic receptor in susceptibility to idiopathic dilated cardiomyopathy 41
null 41
Effetti cardiotossici in pazienti sottoposti a terapia antineoplastica 40
Cardiovascular prevention in women: A narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' 38
QT interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada Sindrome 37
Role of beta1-adrenergic receptor polymorphisms in susceptibility to idiopathic dilated cardiomyopathy 37
Two-dimensional strain measures of left ventricular systolic function are independent predictors of mortality in patients affected by chronic heart failure. 36
QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome 34
Genotypes and phenotypes heterogeneity in PIK3CA-related overgrowth spectrum and overlapping conditions: 150 novel patients and systematic review of 1007 patients with PIK3CA pathogenetic variants 34
Genetic evaluation of Brugada sindrome 31
A novel LMNA gene mutation in a multigenerational family with arrhythmogenic cardiac laminopathy 30
null 28
Natriuretic peptides and essential arterial hypertension 27
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 27
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 26
Role of beta2-adrenergic receptor polymorphisms in predicting lower risk for major arrhythmic events in idiopathic dilated cardiomyopathy 25
SCN5A polymorphism rescues Brugada Syndrome Mutation 25
Bifocal coronary sinus pacing and transcatheter tricuspid valve-in-valve implantation: an innovative combined approach 23
Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis? 22
Inflammatory bowel disease and acute coronary syndromes: From pathogenesis to the fine line between bleeding and ischemic risk. 22
Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X 21
Independent and incremental prognostic role of two-dimensional speckle tracking analysis of left ventricular systolic function in predicting heart failure outpatients’ prognosis 21
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 21
A Young Patient Presenting with Dilated Cardiomyopathy and Renal Infarction during Treatment with Isotretinoin: Mere Coincidence or Serious Side Effect of a Drug Commonly Used in Adolescence? 20
Predictors of exercise capacity in dilated cardiomyopathy with focus on pulmonary venous flow recorded with transesophageal eco-doppler 20
Cardiac Magnetic Resonance as Risk Stratification Tool in Non-Ischemic Dilated Cardiomyopathy Referred for Implantable Cardioverter Defibrillator Therapy—State of Art and Perspectives 18
The expression of Lamin A mutant R321X leads to endoplasmic reticulum stress with aberrant Ca(2+) handling 18
Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone 18
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 16
Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience 16
Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients 15
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 14
Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study 14
Role of pre-operative embolization in carotid body tumor surgery according to Shamblin classification: A systematic review and meta-analysis 14
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 12
Clinical use of cangrelor: a real-world multicenter experience from South Italy 12
Totale 5.586
Categoria #
all - tutte 26.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020657 0 0 0 0 0 82 128 109 143 71 94 30
2020/2021694 51 41 49 35 46 36 74 52 58 107 90 55
2021/2022630 40 83 15 21 22 44 31 30 45 51 104 144
2022/20231.071 127 116 75 94 129 140 12 113 196 11 31 27
2023/2024419 31 68 18 36 34 89 18 26 11 16 13 59
2024/2025680 114 20 138 100 130 178 0 0 0 0 0 0
Totale 5.741